Time to Understand the Infrequency of the Frequent Exacerbator Phenotype in COPD

Affiliations

¹ Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.
² Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI; Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, NY. Electronic address: fjm2003@med.cornell.edu.

Editorial

Wassim W Labaki et al. Chest. 2018 May.

. 2018 May;153(5):1087-1088.

doi: 10.1016/j.chest.2018.01.056.

¹ Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.
² Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI; Division of Pulmonary and Critical Care Medicine, Weill Cornell Medical College, New York, NY. Electronic address: fjm2003@med.cornell.edu.

No abstract available

Comment on

Defining the "Frequent Exacerbator" Phenotype in COPD: A Hypothesis-Free Approach.
Le Rouzic O, Roche N, Cortot AB, Tillie-Leblond I, Masure F, Perez T, Boucot I, Hamouti L, Ostinelli J, Pribil C, Poutchnine C, Schück S, Pouriel M, Housset B. Le Rouzic O, et al. Chest. 2018 May;153(5):1106-1115. doi: 10.1016/j.chest.2017.10.009. Epub 2017 Oct 17. Chest. 2018. PMID: 29054347

Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry.
Fortis S, Wan ES, Kunisaki K, Eyck PT, Ballas ZK, Bowler RP, Crapo JD, Hokanson JE, Wendt C, Silverman EK, Comellas AP. Fortis S, et al. Respir Med X. 2021 Nov;3:100025. doi: 10.1016/j.yrmex.2020.100025. Epub 2020 Dec 29. Respir Med X. 2021. PMID: 35911870 Free PMC article.
Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
Uslu B, Gülsen A, Arpinar Yigitbas B. Uslu B, et al. Tanaffos. 2022 Mar;21(3):307-316. Tanaffos. 2022. PMID: 37025319 Free PMC article.
Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
Hurst JR, Han MK, Singh B, Sharma S, Kaur G, de Nigris E, Holmgren U, Siddiqui MK. Hurst JR, et al. Respir Res. 2022 Aug 23;23(1):213. doi: 10.1186/s12931-022-02123-5. Respir Res. 2022. PMID: 35999538 Free PMC article.
Development and multimodal characterization of an elastase-induced emphysema mouse disease model for the COPD frequent bacterial exacerbator phenotype.
Rodríguez-Arce I, Morales X, Ariz M, Euba B, López-López N, Esparza M, Hood DW, Leiva J, Ortíz-de-Solórzano C, Garmendia J. Rodríguez-Arce I, et al. Virulence. 2021 Dec;12(1):1672-1688. doi: 10.1080/21505594.2021.1937883. Virulence. 2021. PMID: 34252004 Free PMC article.